Results 191 to 200 of about 110,250 (249)

Timing and Frequency of Surveillance After Resection of Extremity and Trunk Soft Tissue Sarcoma: Identifying Opportunities for Improvement. [PDF]

Ann Surg Oncol
Malik N, Traweek R, Lyu HG, Witt R, Chiang YJ, Cass S, Cope B, Mericli A, Lillemoe HA, Scally C, Torres K, Hunt K, Roland CL, Keung EZ.   +13 more
europepmc   +1 more source

Radiomics of soft tissue sarcoma metastases to assess prognostic factors related to intrapatient intertumor heterogeneity. [PDF]

Transl Cancer Res
Matcuk GR, Fields BKK.
europepmc   +1 more source

Nationwide treatment patterns and outcomes of localised soft tissue sarcoma in Austria: real-world data from the Austrian Sarcoma Registry. [PDF]

J Orthop Surg Res
Smolle MA, Hasenschwandtner S, Reichinger A, Koulaxouzidis G, Wenzl FA, Weiss L, Heregger R, Seeber A, Winder T, Taghizadeh H, Liegl-Atzwanger B, Leithner A, Szkandera J.   +12 more
europepmc   +1 more source

Activation of the STING pathway potentiates the antitumor efficacy of doxorubicin in soft-tissue sarcoma. [PDF]

Front Oncol
Choi W, Lee GY, Kong SY.
europepmc   +1 more source

Neoadjuvant chemotherapy for soft-tissue sarcoma of the extremities: A post-hoc Sarculator-based risk analysis of the EORTC 62961-ESHO 95 randomized trial. [PDF]

Cancer
Albertsmeier M, Milani V, Lindner LH, Tinè G, Pasquali S, Callegaro D, Gronchi A, Dürr HR, Klein A, Di Gioia D, Abdel-Rahman S, Schmidt M, Werner J, von Bergwelt-Baildon M, Miceli R, Issels R.   +15 more
europepmc   +1 more source

Schlafen 11 as a prognostic and potentially predictive biomarker in soft tissue sarcoma: evidence from a real-world cohort. [PDF]

Front Oncol
Simon AG, Lyu SI, Stahl D, Schiffmann LM, Wenk B, Buettner R, Wuerdemann N, Tuchscherer A, Ullrich RT, Quaas A.   +9 more
europepmc   +1 more source

Gelatin-Based Soft-Tissue Sarcoma Organoids Recapitulate Patient Tumor Characteristics. [PDF]

Biomater Res
Han K, Choi J, Kim CE, Kang S, An HI, Pack CG, Ahn JH, Kwon H, Kim CW, Song JS, Kim TW, Tak E, Kim JE.   +12 more
europepmc   +1 more source

MRI-Based Delta Necrosis as a Prognostic Marker Following Neoadjuvant Chemotherapy in Soft Tissue Sarcoma. [PDF]

Cancers (Basel)
Bravo Thompson H, Chattopadhyay P, Subhawong T, Palmer MC, Torralbas Fitz S, Crawford B, Rosenberg A, Temple HT, Jonczak E.   +8 more
europepmc   +1 more source

Correction: Surgery for Retroperitoneal Soft Tissue Sarcoma is Safe Following Multimodal Treatment with Regional Hyperthermia. [PDF]

Ann Surg Oncol
Knoblauch M, Werdel C, Arlt Y, Lindner LH, Di Gioia D, Burkhard-Meier A, Berclaz L, Schmidt-Hegemann NS, Schmidt P, Werner J, Albertsmeier M.   +10 more
europepmc   +1 more source

Prognostic Value of Regnase-1 in High-Grade Soft Tissue Sarcoma: Favourable in UPS, Yet Inverted in Adjuvantly Irradiated Patients. [PDF]

Cancers (Basel)
Zangarini J, Künstner A, Lenz F, Tharun L, Vorwerk J, Gebauer N, Kirfel J, Busch H, Köhler BC, Wardelmann E, Rades D, Löser A, Bubnoff NV, Khandanpour C, Kebenko M.   +14 more
europepmc   +1 more source